FNY Investment Advisers’s BioDelivery Sciences International, Inc. BDSI Stock Holding History

FNY Investment Advisers’s Portfolio BDSI Stock Details BDSI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-500	Closed	-$2K	–	1244
2019 Q3	$2K	Sell	500 -3,428	-87%	-$14.6K	﹤0.01%	786
2019 Q2	$18K	Buy	3,928 +3,428	+686%	+$16K	0.01%	488
2019 Q1	$2K	Hold	500	–	–	﹤0.01%	632
2018 Q4	$1K	Hold	500	–	–	﹤0.01%	649
2018 Q3	$1K	Hold	500	–	–	﹤0.01%	856
2018 Q2	$1K	Buy	+500	New	+$1.19K	﹤0.01%	1020

Other funds holding BDSI

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

NCM

Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return

Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return

RCMNY

Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return

Emerald Advisers Leola, Pennsylvania $4.25B AUM 141.71% 1-Year Est. Return

EMFAT

Emerald Mutual Fund Advisers Trust Leola, Pennsylvania $2.85B AUM 140.52% 1-Year Est. Return

SFM

Systematic Financial Management Teaneck, New Jersey $4.36B AUM 40.56% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

FNY Investment Advisers's BDSI Position: Q4 2019 in Review

FNY Investment Advisers sold out of BioDelivery Sciences International, Inc. (BDSI) in Q4 2019, closing a stake of 500 shares — an estimated $2K sold.

FNY Investment Advisers first reported a position in BDSI in Q2 2018 and held it in 6 quarters. The position peaked at $18K in Q2 2019. 157 funds tracked by Wall St. Rank hold BDSI as of Q4 2019.

FNY Investment Advisers reported no remaining BioDelivery Sciences International, Inc. position as of Q4 2019 after selling out during the quarter.
FNY Investment Advisers sold 500 BioDelivery Sciences International, Inc. shares in Q4 2019, an estimated $2K.
FNY Investment Advisers first reported a position in BioDelivery Sciences International, Inc. in Q2 2018 and held it in 6 quarters.
FNY Investment Advisers's BioDelivery Sciences International, Inc. position peaked at $18K in Q2 2019.
157 funds tracked by Wall St. Rank held BioDelivery Sciences International, Inc. as of Q4 2019.

Based on FNY Investment Advisers's 13F filing for Q4 2019, filed 10 Jan 2020.